Acrivon Therapeutics
ACRV
#9883
Rank
A$0.10 B
Marketcap
A$2.50
Share price
0.57%
Change (1 day)
17.09%
Change (1 year)

Acrivon Therapeutics (ACRV) - Total assets

Total assets on the balance sheet as of March 2026 : A$0.15 Billion

According to Acrivon Therapeutics's latest financial reports the company's total assets are A$0.15 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Acrivon Therapeutics - Total assets on balance sheet (from 2021 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$0.19 B-38.72%
2024-12-31A$0.31 B55.74%
2023-12-31A$0.20 B-23.79%
2022-12-31A$0.26 B81.14%
2021-12-31A$0.14 B5073.84%
2020-12-31A$2.84 M